
Florida man found guilty of murdering pregnant girlfriend who refused abortion
Bridget Sielicki
·
Judge presiding over FDA abortion pill case says he received death threats
The judge presiding over an abortion pill case in Texas recently told attorneys on both sides that his office has received harassment and death threats related to the case.
US District Judge Matthew Kacsmaryk was heavily criticized for not publicizing the first hearing in the case, which took place today. The News Media Coalition called the delay in notifying media about the hearing “unconstitutional,” saying, “The Court cannot constitutionally close the courtroom indirectly when it cannot constitutionally close the courtroom directly.”
Yet it was a decision Kacsmaryk said was necessary.
“To minimize some of the unnecessary death threats and voicemails and harassment that this division has received from the start of the case, we’re going to post that later in the day. So it may even be after business hours, but that will be publicly filed,” he said during a conference call with attorneys. “Other elements of this case have brought a barrage of death threats and protesters and the rest. I don’t want that to disrupt your presentation to the court.”
He also said there were security issues with the courthouse to contend with as well, and the death threats were an issue he reiterated again, while promising he wasn’t trying to stifle journalistic freedom.
“This is not a gag order but just a request for courtesy given the death threats and harassing phone calls and voicemails that this division has received,” he said. “We want a fluid hearing with all parties being heard. I think less advertisement of this hearing is better.”
During the hearing, Kacsmaryk will consider an injunction requested against the Food and Drug Administration (FDA) approval of mifepristone in chemical abortions. More than half of all abortions in the United States are committed using abortion pills, according to a report from the pro-abortion Guttmacher Institute. The FDA is being sued by Alliance Defending Freedom (ADF) on behalf of four medical organizations, claiming that the FDA approved the abortion drugs without studying the safety of the drugs, ignored the potential side effects, and disregarded evidence that chemical abortions are more dangerous than first-trimester surgical abortions.
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Dear Reader,
Every day in America, more than 2,800 preborn babies lose their lives to abortion.
That number should break our hearts and move us to action.
Ending this tragedy requires daily commitment from people like you who refuse to stay silent.
Millions read Live Action News each month — imagine the impact if each of us took a stand for life 365 days a year.
Right now, we’re urgently seeking 500 new Life Defenders (monthly donors) to join us before the end of October. And thanks to a generous $250,000 matching grant, your first monthly gift will be 3X MATCHED to help save lives and build a culture that protects the preborn.
Will you become one of the 500 today? Click here now to become a Live Action Life Defender and have your first gift TRIPLED.
Together, we can end abortion and create a future where every child is cherished and every mother is supported.

Bridget Sielicki
·
Analysis
Nancy Flanders
·
Analysis
Cassy Cooke
·
Analysis
Cassy Cooke
·
Analysis
Sheena Rodriguez
·
Human Rights
Cassy Cooke
·
International
Cassy Cooke
·
Pop Culture
Cassy Cooke
·
Analysis
Cassy Cooke
·
Issues
Cassy Cooke
·
Analysis
Cassy Cooke
·